申请人:Hoechst-Roussel Pharmaceuticals Inc.
公开号:US05202319A1
公开(公告)日:1993-04-13
There are disclosed various compounds of the formula below, ##STR1## where n is 1 or 2; m is 1 or 2; each X is independently hydrogen or loweralkoxy; Y is hydrogen, halogen or trifluoromethyl; R.sub.1 is hydrogen, loweralkyl, arylloweralkyl, heteroarylloweralkyl, pyridinyl, loweralkylcarbonyl, arylloweralkylcarbonyl, heteroarylloweralkylcarbonyl, trifluoromethylcarbonyl or arylcarbonyl; and R.sub.2 is hydrogen, loweralkyl, loweralkoxycarbonyl, aminoloweralkylcarbonyl, loweralkylaminoloweralkylcarbonyl or diloweralkylaminoloweralkylcarbonyl; which are useful as modulators of neurotransmitter function such as serotonergic and adrenergic, and as such are useful as antidepressants and for the treatment of personality disorders such as obsessive compulsive disorders.
下面公式的各种化合物已被披露,其中 n 为 1 或 2;m 为 1 或 2;每个 X 独立地是氢或低烷氧基;Y 是氢、卤素或三氟甲基;R.sub.1 是氢、低烷基、芳基低烷基、杂环芳基低烷基、吡啶基、低烷基羰基、芳基低烷基羰基、杂环芳基低烷基羰基、三氟甲基羰基或芳基羰基;以及 R.sub.2 是氢、低烷基、低烷氧基羰基、氨基低烷基羰基、低烷胺基低烷基羰基或二低烷胺基低烷基羰基;这些化合物可用作神经递质功能的调节剂,如选择性5-羟色胺和肾上腺素,因此可用作抗抑郁药物和治疗个性障碍,如强迫性障碍。